Amtagvi, a cellular therapy for solid tumors, has received FDA fast-track approval, offering hope for patients who have exhausted other treatment options for metastatic melanoma, a particularly deadly form of skin cancer.
Join the fight for freedom
Be the first to know: Stories from The Washington Informer in your inbox each weekday.
